The mRNA-Based Therapy Landscape Infographic

The mRNA-Based Therapy Landscape

The attention on mRNA-based therapies has continuously increased over the past decade, with a surge coming as a result of the mRNA-based COVID-19 vaccine success. With mRNA therapeutics continuing to grow beyond COVID-19, it is hard to keep track of this booming landscape.

Due to the current focus on their activity and potential, and in partnership with the mRNA-Based Therapeutics Summit, our Beacon RNA team have created an infographic of the landscape so far.

mRNA-Based Therapy Landscape Infographic

Here are some of the key highlights covered in the infographic.

Current Status of mRNA-Based Therapies
Top Drug Developers in the mRNA Space
mRNA Therapies by Number of Trials and Trials Initiation
Top Disease Indications Across Non-Oncology & Oncology Landscapes
Top Delivery Systems Across the mRNA Landscape

Download Infographic

You May Also Be Interested In…

ASGCT 2026: RNA Post-Conference Report

Access Report

RNA Therapeutics for CVRM Disorders

View Market Report

RNA 2025 Landscape Review

Access Review

View All

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration